This is the biggest cut to SNAP in its history, and it is coming against the backdrop of rising food prices and a fragile ...
The first botulinum toxin product, onabotulinumtoxinA, was approved by the FDA in 1989. Since then, FDA has approved several ...
The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 ...
Selective decontamination of the digestive tract (SDD) did not lower in-hospital deaths among patients undergoing mechanical ...
The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...
Sun Pharmaceutical issued a voluntary recall of lisdexamfetamine dimesylate capsules, used for attention ...
"Our findings highlight the interconnectedness of heart and vascular health with brain health in middle-aged and older adults ...
Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same ...
Primary nephrotic syndrome in adults, including minimal-change nephrotic syndrome, has an incidence of roughly 0.2 to 0.8 per ...
The FDA in September approved elamipretide (Forzinity) as the first treatment for the ultra-rare Barth syndrome despite ...
Physician groups were generally dissatisfied with the final 2026 Medicare Physician Fee Schedule rule released late last week by the Centers for Medicare & Medicaid Services (CMS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback